NL-OMON20029暂停不适用
High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study.
The study is conducted on the department of hematology in het University Medical Center Utrecht. The study is approved by the Medical Ethical Board of this same hospital.0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Multiple myeloma patients;
- •2. At least two cycles of chemotherapy with adriamycin and dexamethasone;
排除标准
- •1. Inadequate hepatic and renal function.
研究者
相似试验
已完成
2 期
High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II studyMultiple myelomaCancerISRCTN85384018niversity Medical Centre Utrecht (UMCU) (The Netherlands)12
进行中（未招募）
不适用
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidEUCTR2011-004361-32-DEPhilipps-Universität Marburg
进行中（未招募）
2 期
Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoidA prospective multi-centre randomised double-blind placebo-controlled pilot studyL12.0Bullous pemphigoidDRKS00003851Philipps-Universität Marburg1
进行中（未招募）
1 期
Research on the effect of add-on high dosage simvastatin treatment on progression in MS patients treated with ocrelizumab and natalizumab.Multiple sclerosisEUCTR2019-003127-38-NLVUmc Neurology Department100
尚未招募
2 期
Efficacy of add-on high-dose simvastatin on markers for disease progression in MS patients treated with ocrelizumab and natalizumab (SIMSON), a phase II clinical trial.Multiple sclerosis10012303MSNL-OMON49976Vrije Universiteit Medisch Centrum100